Table: OncoTherapy Science - 9-MTH group results

OncoTherapy Science

07/02/2020 08:00

Feb 7 (Reuters)- 
             OncoTherapy Science Inc 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to 
                Dec 31, 2019        Dec 31, 2018     Mar 31, 2020 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales            161 mln             247 mln                    
                 (-34.8 pct)         (+22.0 pct)                  
  Operating       loss 1.74           loss 2.15                   
  Recurring       loss 1.74           loss 2.15                   
  Net             loss 1.78           loss 1.89                   
  EPS          loss 11.16 yen      loss 12.89 yen                 
  Ann Div                                NIL              NIL     
  -Q2 div
  -Q4 div                                NIL              NIL     
  
  NOTE - OncoTherapy Science Inc. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4564.T